时间：2020-07-22 08:16:40人气：8560来源： 迪拜新闻网
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)
A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
The Medical Stories in the War: the Spirit of Internationalism with Boundless Love
(5994)人喜欢2025-12-01
LABUBU joins New York's Thanksgiving Parade
(5993)人喜欢2025-11-30
Lifeline in the Flames: The Past and Present of China’s Wartime Arteries
(6009)人喜欢2025-11-25
'Phone Tap' tax refunds boost China shopping appeal
(4366)人喜欢2025-11-24
Senior Japanese official leaves China's Foreign Ministry without any response to media
(6003)人喜欢2025-11-19
China's Shenzhou-20 crew returns to Earth
(6007)人喜欢2025-11-15
China Eastern resumes Shanghai–Delhi passenger flights
(6009)人喜欢2025-11-11
World's first industrial 5G standard led by China, Germany published
(6011)人喜欢2025-11-07